OBJECT: To evaluate how spinning rate affects mobile lipid (ML) resonances visibility in HR-MAS spectra of C6 glioma cells and artificial oil bodies (AOB), as models of cytosolic lipid droplets. MATERIALS AND METHODS: Using C6 cells and AOB of two different sizes, 780 ± 580 and 240 ± 293 nm, as models, we acquired HR-MAS pulse and acquire spectra at different spinning rates between 500 and 15,000 Hz, all at 37 °C. RESULTS: Sample spinning at 15,000 Hz increased by 2.3 and 4.6-fold with respect to 500 Hz spinning the area of resonances corresponding to ML at 0.88 and 1.28 ppm, respectively, for log phase C6 cells. Furthermore, postconfluent C6 cells displayed an increase of 2.5-fold at 0.88 ppm and 4.2-fold at 1.28 ppm. These changes were reversible upon low speed spinning. AOBs did show much lower ML area increases (1.4-1.5-fold) upon high-speed HR-MAS. CONCLUSION: ML can be reversibly mobilized in C6 glioma cells by high-speed HR-MAS, partially unveiling the NMR "invisible" ML pool. A small part of the ML pool also shows reduced visibility in freely tumbling AOBs.
OBJECT: To evaluate how spinning rate affects mobile lipid (ML) resonances visibility in HR-MAS spectra of C6 glioma cells and artificial oil bodies (AOB), as models of cytosolic lipid droplets. MATERIALS AND METHODS: Using C6 cells and AOB of two different sizes, 780 ± 580 and 240 ± 293 nm, as models, we acquired HR-MAS pulse and acquire spectra at different spinning rates between 500 and 15,000 Hz, all at 37 °C. RESULTS: Sample spinning at 15,000 Hz increased by 2.3 and 4.6-fold with respect to 500 Hz spinning the area of resonances corresponding to ML at 0.88 and 1.28 ppm, respectively, for log phase C6 cells. Furthermore, postconfluent C6 cells displayed an increase of 2.5-fold at 0.88 ppm and 4.2-fold at 1.28 ppm. These changes were reversible upon low speed spinning. AOBs did show much lower ML area increases (1.4-1.5-fold) upon high-speed HR-MAS. CONCLUSION: ML can be reversibly mobilized in C6 glioma cells by high-speed HR-MAS, partially unveiling the NMR "invisible" ML pool. A small part of the ML pool also shows reduced visibility in freely tumbling AOBs.
Authors: Daniel Valverde-Saubí; Ana Paula Candiota; Maria Antònia Molins; Miguel Feliz; Oscar Godino; Myriam Dávila; Juan José Acebes; Carles Arús Journal: MAGMA Date: 2010-06-13 Impact factor: 2.310
Authors: Olaf Beckonert; Muireann Coen; Hector C Keun; Yulan Wang; Timothy M D Ebbels; Elaine Holmes; John C Lindon; Jeremy K Nicholson Journal: Nat Protoc Date: 2010-05-13 Impact factor: 13.491
Authors: C Rémy; N Fouilhé; I Barba; E Sam-Laï; H Lahrech; M G Cucurella; M Izquierdo; A Moreno; A Ziegler; R Massarelli; M Décorps; C Arús Journal: Cancer Res Date: 1997-02-01 Impact factor: 12.701
Authors: Edward J Delikatny; Wendy A Cooper; Susan Brammah; Nalayini Sathasivam; Darryl C Rideout Journal: Cancer Res Date: 2002-03-01 Impact factor: 12.701
Authors: Yolanda Pérez; Hana Lahrech; Miquel E Cabañas; Ramon Barnadas; Manel Sabés; Chantal Rémy; Carles Arús Journal: Cancer Res Date: 2002-10-15 Impact factor: 12.701
Authors: Elena Jiménez-Xarrié; Myriam Davila; Sara Gil-Perotín; Andrés Jurado-Rodríguez; Ana Paula Candiota; Raquel Delgado-Mederos; Silvia Lope-Piedrafita; José Manuel García-Verdugo; Carles Arús; Joan Martí-Fàbregas Journal: J Cereb Blood Flow Metab Date: 2015-01-21 Impact factor: 6.200